Farther Finance Advisors, LLC Vyne Therapeutics Inc. Transaction History

Farther Finance Advisors, LLC

  • $5 Trillion
  • Q2 2025

A detailed history of Farther Finance Advisors, LLC transactions in Vyne Therapeutics Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 16 shares of VYNE stock, worth $5. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16
Holding current value
$5
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 11, 2025
BUY
$0.89 - $1.88 $14 - $30
16 New
16 $26,000

Others Institutions Holding VYNE

# of Institutions
3
Shares Held
51.5K
Call Options Held
0
Put Options Held
0
View Full List

About VYNE Therapeutics Inc.

VYNE Quotes by TradingView
  • Ticker VYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,005,600
  • Market Cap $20.3M
  • Description
  • VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...
More about VYNE
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email